ÂÜÀòÂÒÂ×

Alison Mahan is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as Vice President of Program Leadership at Neumora. Mahan has held various leadership roles, including Senior Director and Program Team Lead at Ultragenyx Pharmaceutical Inc. and Gilead Sciences, where responsibilities encompassed portfolio strategy, analytics, and R&D operations. Prior to these positions, Mahan gained valuable experience as an Associate at McKinsey & Company and completed a post-doctoral fellowship at the Ragon Institute of MGH, MIT, and Harvard. Educational credentials include a Doctor of Philosophy (PhD) in Virology from Harvard University and a Bachelor of Arts in Biology from Reed College.